Ki-67 to Predict Recurrence and Survival of Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Genc, C. [1 ]
Falconi, M. [2 ,3 ]
Partelli, S. [2 ,3 ]
Muffatti, F. [2 ,3 ]
Van Eeden, S. [1 ]
Doglioni, C. [2 ,3 ]
Klumpen, H. J. [1 ]
Van Eijck, C. [4 ]
Van Dijkum, Nieveen E. [1 ]
机构：
[1] Acad Med Ctr Amsterdam, Amsterdam, Netherlands
[2] San Rafaelle Hosp, Milan, Italy
[3] Univ Milan, Milan, Italy
[4] Erasmus MC, Rotterdam, Netherlands
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
neuroendocrine tumors; pancreas; recurrence; survival; ki-67 proliferation index; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D26
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] Ki-67 scoring in neuroendocrine tumors of the pancreas: Alternative solutions
    Cinar, E.
    Aykutlu, U.
    Basar, E.
    Uguz, A.
    Uluer, H.
    Ipek, F. N.
    Coker, A.
    Yilmaz, F.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 289 - 289
  • [22] Evaluation of Ki-67 (MIB-1) Labeling Index With Dual-Color Immunocytochemistry (Ki-67 with LCA) for Grading of Pancreatic Neuroendocrine Tumors
    Mejias, Linette
    Bhalla, Amarpreet
    Salem, Nagla
    Thomas, Sumi
    Shidham, Vinod
    MODERN PATHOLOGY, 2015, 28 : 520A - 520A
  • [23] Ki-67 is a reliable pathological grading marker for neuroendocrine tumors
    Nadler, Ashlie
    Cukier, Moises
    Rowsell, Corwyn
    Kamali, Sepideh
    Feinberg, Yael
    Singh, Simron
    Law, Calvin H. L.
    VIRCHOWS ARCHIV, 2013, 462 (05) : 501 - 505
  • [24] Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors
    Yijing Xie
    Shipeng Zhang
    Xianwang Liu
    Xiaoyu Huang
    Qing Zhou
    Yongjun Luo
    Qian Niu
    Junlin Zhou
    Japanese Journal of Radiology, 2022, 40 : 823 - 830
  • [25] Ki-67 assessment in pancreatic neuroendocrine tumors: is EUS-FNA still a valid ally?
    Valdivia, Pablo Cortegoso
    Rizza, Stefano
    De Angelis, Claudio Giovanni
    PANCREATOLOGY, 2021, 21 (02) : 496 - 497
  • [26] Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors
    Xie, Yijing
    Zhang, Shipeng
    Liu, Xianwang
    Huang, Xiaoyu
    Zhou, Qing
    Luo, Yongjun
    Niu, Qian
    Zhou, Junlin
    JAPANESE JOURNAL OF RADIOLOGY, 2022, 40 (08) : 823 - 830
  • [27] Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors
    Trynda N. Kroneman
    Jesse S. Voss
    Christine M. Lohse
    Tsung-Teh Wu
    Thomas C. Smyrk
    Lizhi Zhang
    Endocrine Pathology, 2015, 26 : 255 - 262
  • [28] Longitudinal Increase in Ki-67 and High-Grade Transformation in Pancreatic Neuroendocrine Tumors (PNETs)
    Botling, J.
    Lamarca, A.
    Bajic, D.
    Norlen, O.
    Lonngren, V
    Eriksson, B.
    Welin, S.
    Hellman, P.
    Rindi, G.
    Skogseid, B.
    Crona, J.
    NEUROENDOCRINOLOGY, 2019, 108 : 114 - 114
  • [29] Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 Immunostaining
    Jamali, Mina
    Chetty, Runjan
    ENDOCRINE PATHOLOGY, 2008, 19 (04) : 282 - 288
  • [30] Ki-67 is a reliable pathological grading marker for neuroendocrine tumors
    Ashlie Nadler
    Moises Cukier
    Corwyn Rowsell
    Sepideh Kamali
    Yael Feinberg
    Simron Singh
    Calvin H. L. Law
    Virchows Archiv, 2013, 462 : 501 - 505
12345